The never ending success story of tranexamic acid in acquired bleeding

Tranexamic acid (TXA) is an anti-fibrinolytic agent that acts by inhibiting plasminogen activation and fibrinolysis. Although its first clinical use dates back more than 50 years, this hemostatic agent is still the object of intense clinical and developmental research. In particular, renewed interes...

Full description

Bibliographic Details

Published in:	Haematologica (Roma) Vol. 105; no. 5; pp. 1201 - 1205
Main Authors:	Franchini, Massimo, Mannucci, Pier Mannuccio
Format:	Journal Article
Language:	English
Published:	Italy Ferrata Storti Foundation 01-05-2020
Subjects:	Antifibrinolytic Agents - therapeutic use Blood Loss, Surgical Blood Transfusion Humans Review Thromboembolism Tranexamic Acid
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!